Last checked at 3 Oct 2008 14:58
| For Immediate Release | 3 October 2008 |
Advanced Medical Solutions Group plc
("AMS" or "the Group")
Result of Extraordinary General Meeting
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, announces that the resolution put forward at this morning's Extraordinary General Meeting to approve and adopt new Articles of Association was duly passed.
The resolution was proposed following recent changes to company law as a result of the implementation of the Companies Act 2006.
For further information, please contact:
| Advanced Medical Solutions Group plc | +44 (0) 1606 545508 |
| Don Evans, Chief Executive Officer | |
| Mary Tavener, Group Finance Director | |
| www.admedsol.com | |
| Buchanan Communications | +44 (0) 20 7466 5000 |
| Mark Court / Mary-Jane Johnson / Stasa Filiplic | |
| Landsbanki Securities (UK) Ltd Shaun Dobson, Claes Spang | +44 (0) 20 7426 9000 |
Notes to Editors:
Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.
Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.
In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. AMS has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.
The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market.
AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection.
AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.